Delivery Order SPE2DB22D3004-SPE2DB25FPP79

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,574.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Cosentyx, a specialty pharmaceutical product for the treatment of various medical conditions. The award has a firm fixed price and an ultimate completion date of December 12, 2024. The contract is not associated with any set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,773.72 Firm Fixed Price Delivery Order covers the supply of Cosentyx, a specialty medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx, a specialty medication. The contract has a ceiling value of $3,149.12 and an ultimate completion date of December 6, 2024. It is a delivery order contract with a firm fixed price pricing structure. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $6,782.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, to procure Cosentyx, a specialty medication. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,502.50 fixed-price delivery order is for the supply of Cosentyx, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $4,723.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the specialty medication Cosentyx (300mg dose) and has a completion date of January 17, 2025. This appears to be a specific delivery order against a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,565.85, is for the delivery of Cosentyx, a specialty medication used for various medical conditions. The contract has a Firm Fixed Price pricing type and a completion date of September 5, 2024. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award, valued at $6,275.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under the company's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the supply of Cosentyx (300 mg dose) medication. The contract has a completion date of November 6, 2024 and utilizes a firm fixed-price pricing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Cosentyx, a specialty medication. The $11,507.47 firm fixed price contract has an ultimate completion date of January 13, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx, a specialty medication. The $3,892.36 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPP79
    Delivery Order

This federal contract award, valued at $3,802.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cosentyx, a specialty medication, and has a completion date of February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There is no set-aside designation for this specific award.

Generated 5/21/25, 9:44 AM